Li, S., Krüger, J., Liu, G., Ma, H., Hughes, M. S., Chakraborty, R., . . . Fu, J. (2025). GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism. Elsevier.
Chicago Style (17th ed.) CitationLi, Shirong, et al. GCK Inhibition Enhances Iberdomide Antimyeloma Effects by Promoting IKZF1 Degradation via a CRBN-independent Mechanism. Elsevier, 2025.
MLA (9th ed.) CitationLi, Shirong, et al. GCK Inhibition Enhances Iberdomide Antimyeloma Effects by Promoting IKZF1 Degradation via a CRBN-independent Mechanism. Elsevier, 2025.
Warning: These citations may not always be 100% accurate.